Site icon pharmaceutical daily

2020 Biologic Drug Product Contract Manufacturer Quality Benchmarking Report – Optimize Operational and Marketing Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (3rd Edition)” report has been added to ResearchAndMarkets.com’s offering.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing. In this Consumer Reports-style analysis, the research presents data on 524 service encounters from 134 respondents who have been involved in outsourced drug product projects in the past 18 months.

This report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions and help CMOs optimize operational and marketing strategies.

Drug developers:

Contract Manufacturers:

Key Topics Covered:

1. Outsourcing Philosophies and Practices

2. CMO Selection Drivers

3. CMO Perceptions and Interactions

4. CMO Performance and Loyalty

5. Biologic Drug Product CMO Competitive Landscape

6. Company Service Quality Profiles

7. Study Data

8. Demographics

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/f2430b

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version